ChristianFrederickMeyerMD

Oncology • Baltimore, MD

Instructor of Oncology, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Meyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Meyer's full profile

Already have an account?

Office
201 North Broadway Street
Viragh BLDG 5th FL
Baltimore, MD 21287
Phone+1 410-955-8964

Fax+1 410-367-2194

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
University of MarylandResidency, Internal Medicine, 2001 - 2005
Baylor College of MedicineClass of 2001

Certifications & Licensure

MD State Medical License 2004 - 2025
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Development of Algorithms to Predict Hemodynamic Instability Start of enrollment: 2010 Sep 01
Completed
Dietary Nitrate and Cardiovascular Health Start of enrollment: 2010 Nov 01
Completed
Not Applicable
Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies Start of enrollment: 2013 Oct 01
Completed
Phase 1
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma Start of enrollment: 2016 Mar 01
Completed
Phase 1, Phase 2
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Start of enrollment: 2019 Feb 08
Active, not recruiting
Phase 3
A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS) Start of enrollment: 2019 Mar 13
Completed
Phase 1
Roles: Principal Investigator, Contact
Study of INBRX-109 in Conventional Chondrosarcoma Start of enrollment: 2021 Sep 23
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study.
Aung Naing, Amit Mahipal, Milind Javle, Judy Wang, Todd M Bauer
Journal of Immunotherapy and Precision Oncology. 2025-02-01
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC...
Yvonne M Mowery, Karla V Ballman, Angela M Hong, Scott M Schuetze, Andrew J Wagner
Lancet. 2024-11-23
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.
R Taylor Sundby, Jeffrey J Szymanski, Alexander C Pan, Paul A Jones, Sana Z Mahmood
Clinical Cancer Research. 2024-10-01

Press Mentions

Thumbs up from FDA Panel for Sarcoma DrugDecember 18th, 2019

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/christian-meyer